The Drug Regulatory Authority of Pakistan (DRAP) has issued an immediate nationwide recall for specific batches of disposable syringes, citing critical failures in sterility standards. The health regulator warned hospitals, pharmacies, and patients to stop using these products immediately to prevent the risk of bloodstream infections and other complications.
The alert follows reports of contaminated batches entering the supply chain. DRAP’s quality control division identified that the packaging integrity of these specific units was compromised, rendering the internal contents non-sterile.
“We are pulling these batches from the market because we cannot guarantee patient safety,” a senior DRAP official told reporters during a brief briefing in Islamabad. “Any facility holding these items must quarantine them and return them to the supplier immediately.”
The recall targets specific manufacturing codes—details of which are available on the official DRAP website—that were distributed across major urban centers, including Karachi, Lahore, and Islamabad. Investigators are currently looking into whether the breach occurred during the manufacturing process or during the transit and storage phase.
For patients and medical practitioners, the stakes are high. Using a non-sterile syringe introduces a direct risk of sepsis, abscesses, and the transmission of blood-borne pathogens. Doctors are now being instructed to verify the batch numbers on all syringe packaging before administering any medication or drawing blood.
This isn’t the first time the regulator has flagged medical equipment, but the scope of this recall has prompted a wider audit of local syringe manufacturers. The regulator plans to conduct surprise inspections at production facilities over the next 48 hours to ensure compliance.
If you have purchased syringes recently, check the packaging against the serial numbers listed on the DRAP portal. If the batch matches the recall list, dispose of the items in a sealed bin and notify your local pharmacy.
The regulator expects to release a full list of affected distributors by the end of the business day. For now, the focus remains on clearing pharmacy shelves before these items reach the hands of patients.
